SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 30th, 2020 • Qrons Inc. • Biological products, (no disgnostic substances)
This securities purchase agreement (this “Agreement”) is made by and between Qrons Inc., a Wyoming corporation (the "Company"), and __________________, a citizen and resident of the State of _________________ (the “Undersigned”) as of December ___, 2019. The Undersigned hereby irrevocably agrees to purchase the Company’s eight percent (8%) convertible promissory note, issued in the amount of $_____________, the form of which is attached hereto as Exhibit A (the “Note”), which Note is and shall be, at the option of the Undersigned except as therein stated, convertible in accordance with its terms into shares of common stock of the Company, par value $0.0001 per share, which common stock trades on the OTC Markets “OTC-QB” under the symbol “QRON” ("Common Stock"). In addition to the Note, and as a material part of the Purchase Price (defined below), the Company shall issue to the Undersigned a warrant (the “Warrant”) to purchase _________ shares [one (1) share per dollar invested] of Comm
THIRD AMENDMENT TO SERVICES AGREEMENTServices Agreement • March 30th, 2020 • Qrons Inc. • Biological products, (no disgnostic substances)
This Third Amendment to the Services Agreement, dated December 8, 2019, to the Services Agreement, dated December 14, 2017 between Ariel Scientific Innovations Ltd., a company organized under the laws of Israel ("Ariel"), and Qrons Inc., a Wyoming corporation (the “Company”). as amended by First Amendment to Services Agreement, dated April 12, 2018 and a Second Amendment to Services Agreement dated Dec. 14, 2018 (collectively, the “Services Agreement”)
